MIT Researchers Develop Bioresorbable Batteries for Ingestible Medical Devices
New ingestible power sources safely dissolve in the body while enabling advanced medical monitoring.
1The Danger of Ingestion
Standard button batteries pose severe health risks, including caustic chemical burns and electrical damage. A swallowed battery can perforate a child's throat within two hours, creating a medical emergency. Current ingestible capsules often rely on these hazardous power sources or limited wireless energy, necessitating a safer, more reliable alternative for internal medical diagnostics.
2Bioresorbable Battery Composition
MIT researchers engineered a paper-like battery utilizing magnesium and molybdenum trioxide, materials the human body tolerates in small quantities. The device employs an ionic liquid gel as its electrolyte, producing 1.84 volts. This bioresorbable design ensures the battery fully breaks down and absorbs within weeks, eliminating the need for surgical retrieval after use.
3Operational Lifespan and Testing
The battery remains functional for approximately three days before the degradation process begins. While current development has focused on animal models, the results demonstrate consistent performance. This innovation marks a significant shift from previous external power reliance, allowing for longer-term internal device operation without the toxicity risks associated with traditional coin-cell battery components.
4Treating Chronic Appetite Loss
Patients suffering from cancer, HIV, or dementia often experience cachexia and dangerous weight loss. MIT researchers successfully used the battery to power a device that stimulates the stomach lining. This electrical stimulation triggers ghrelin production, the hunger hormone. In animal tests, just 20 minutes of stimulation increased ghrelin levels by approximately 50 percent.
5Enhancing Medication Adherence
Medication non-adherence remains a primary cause of preventable morbidity and rising healthcare costs. By integrating radio frequency identification tags into these capsules, medical professionals can remotely verify patient compliance. Unlike previous battery-free tags that relied on limited energy harvesting, this new power source enables continuous transmission from the gastrointestinal tract to external receivers.
6Extended Transmission Range
The integration of the bioresorbable battery significantly improves the functionality of internal RFID tags. Animal testing confirmed that the device can transmit data continuously from within the gastrointestinal tract at a range of up to 1.5 meters. This increased range provides greater flexibility for monitoring patients without requiring them to remain near specialized equipment.
7Comparative Medical Innovations
This project contrasts with other MIT initiatives, such as vibrating capsules designed to treat obesity. While those devices focus on mechanical intervention, the bioresorbable battery provides a versatile power platform for diverse medical applications. The ability to safely power internal electronics opens new pathways for treating chronic conditions through targeted, localized electrical or chemical delivery.
8Future Clinical Implications
The transition from animal testing to human clinical trials remains the next critical milestone for this technology. By replacing toxic components with safe, absorbable materials, this development could revolutionize how doctors monitor internal health and manage chronic diseases. The technology effectively bridges the gap between complex medical diagnostics and patient safety in ambulatory settings.